GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Monday, 29 Sep 2014 | 6:02 PM ET

    Amgen Inc. fell$. 99 or. 7 percent, to $140.07. Biogen Idec fell $3.38 or 1.0 percent, to $330.16. Celgene Corp. rose $1.18 or 1.2 percent, to $95.64.

  • Midday Glance: Biotechnology companies Monday, 29 Sep 2014 | 1:51 PM ET

    Amgen Inc. fell $1.25 or. 9 percent, to $139.81. Biogen Idec fell $3.94 or 1.2 percent, to $329.60. Celgene Corp. rose$. 28 or. 3 percent, to $94.74.

  • Early Glance: Biotechnology companies Monday, 29 Sep 2014 | 10:36 AM ET

    Amgen Inc. fell $1.15 or. 8 percent, to $139.91. Biogen Idec fell $5.54 or 1.7 percent, to $328.00. Celgene Corp. fell$. 72 or. 8 percent, to $93.74.

  • Final Glance: Biotechnology companies Friday, 26 Sep 2014 | 6:01 PM ET

    Amgen Inc. rose $1.21 or. 9 percent, to $141.06. Biogen Idec rose$. 14 or percent, to $333.54. Celgene Corp. rose $1.30 or 1.4 percent, to $94.46.

  • Midday Glance: Biotechnology companies Friday, 26 Sep 2014 | 1:17 PM ET

    Amgen Inc. fell$. 49 or. 4 percent, to $139.36. Biogen Idec fell $4.52 or 1.4 percent, to $328.88. Celgene Corp. rose$. 25 or. 3 percent, to $93.41.

  • Early Glance: Biotechnology companies Friday, 26 Sep 2014 | 11:12 AM ET

    Amgen Inc. fell$. 75 or. 5 percent, to $139.10. Biogen Idec fell$. 57 or. 2 percent, to $332.83. Celgene Corp. rose$. 59 or. 6 percent, to $93.75.

  • Final Glance: Biotechnology companies Thursday, 25 Sep 2014 | 6:01 PM ET

    Amgen Inc. fell $2.39 or 1.7 percent, to $139.85. Biogen Idec fell $12.90 or 3.7 percent, to $333.40. Celgene Corp. fell $3.05 or 3.2 percent, to $93.16.

  • Midday Glance: Biotechnology companies Thursday, 25 Sep 2014 | 1:24 PM ET

    Amgen Inc. fell $2.26 or 1.6 percent, to $139.98. Biogen Idec fell $11.91 or 3.4 percent, to $334.39. Celgene Corp. fell $2.75 or 2.9 percent, to $93.46.

  • Early Glance: Biotechnology companies Thursday, 25 Sep 2014 | 11:40 AM ET

    Amgen Inc. rose$. 03 or percent, to $142.27. Biogen Idec fell $5.18 or 1.5 percent, to $341.13. Celgene Corp. fell $1.22 or 1.3 percent, to $94.99.

  • Final Glance: Biotechnology companies Wednesday, 24 Sep 2014 | 6:02 PM ET

    Amgen Inc. rose $1.56 or 1.1 percent, to $142.24. Biogen Idec rose $14.06 or 4.2 percent, to $346.30. Celgene Corp. rose $3.09 or 3.3 percent, to $96.21.

  • Indexes added to gains and hit session highs after Chicago Federal Reserve Bank President Charles Evans said the central bank should be "exceptionally patient" in removing monetary policy accommodation at a Peterson Institute conference on labor market slack.

  • US STOCKS-Biotechs climb after two-day drop Wednesday, 24 Sep 2014 | 1:48 PM ET

    NEW YORK, Sept 24- Biotech stocks are moving higher on Wednesday, bouncing back from a two-day drop, helped by gains in Gilead Sciences after trial results for the company's HIV treatment.

  • Midday Glance: Biotechnology companies Wednesday, 24 Sep 2014 | 1:21 PM ET

    Amgen Inc. rose $1.29 or. 9 percent, to $141.97. Biogen Idec rose $11.33 or 3.4 percent, to $343.57. Celgene Corp. rose $2.35 or 2.5 percent, to $95.47.

  • Early Glance: Biotechnology companies Wednesday, 24 Sep 2014 | 10:33 AM ET

    Amgen Inc. fell$. 39 or. 3 percent, to $140.29. Biogen Idec rose $4.49 or 1.4 percent, to $336.73. Celgene Corp. rose $1.17 or 1.3 percent, to $94.29.

  • Gilead's HIV drug shows potential in two mid-stage studies Wednesday, 24 Sep 2014 | 10:20 AM ET

    Sept 24- Gilead Sciences Inc said its HIV tablet containing tenofovir alafenamide was found better than its approved drug, Stribild, in two mid-stage studies. The company's shares rose 1.3 percent to $106.77 in early trading on the Nasdaq on Wednesday.

  • Final Glance: Biotechnology companies Tuesday, 23 Sep 2014 | 6:03 PM ET

    Amgen Inc. fell $1.50 or 1.1 percent, to $140.68. Biogen Idec rose $2.48 or. 8 percent, to $332.24. Celgene Corp. rose$. 93 or 1.0 percent, to $93.12.

  • Midday Glance: Biotechnology companies Tuesday, 23 Sep 2014 | 1:19 PM ET

    Amgen Inc. fell $1.06 or. 7 percent, to $141.12. Biogen Idec rose $3.25 or 1.0 percent, to $333.01. Celgene Corp. rose$. 67 or. 7 percent, to $92.86.

  • Early Glance: Biotechnology companies Tuesday, 23 Sep 2014 | 10:29 AM ET

    Amgen Inc. fell$. 60 or. 4 percent, to $141.58. Biogen Idec rose $1.73 or. 5 percent, to $331.49. Celgene Corp. rose$. 59 or. 6 percent, to $92.78.

  • Final Glance: Biotechnology companies Monday, 22 Sep 2014 | 6:03 PM ET

    Amgen Inc. fell $1.83 or 1.3 percent, to $142.18. Biogen Idec rose$. 52 or. 2 percent, to $329.76. Celgene Corp. fell $1.66 or 1.8 percent, to $92.19.

  • Midday Glance: Biotechnology companies Monday, 22 Sep 2014 | 2:12 PM ET

    Amgen Inc. fell $2.75 or 1.9 percent, to $141.26. Biogen Idec fell $2.59 or. 8 percent, to $326.65. Celgene Corp. fell $1.94 or 2.1 percent, to $91.91.